证券代码：688090 证券简称：瑞松科技 公告编号：2025-034 广州瑞松智能科技股份有限公司 关于子公司涉及诉讼事项的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示: 案件所处的诉讼阶段：部分案件一审已判决，尚处于上诉期内。 上市公司所处的当事人地位：广州瑞松智能科技股份有限公司（以下简 称"公司"）控股子公司广州瑞松北斗汽车装备有限公司（以下简称"广州瑞北" 或）为本案原告。 涉案金额：涉案的金额为人民币 2,513.24 万元（未含逾期付款利息、诉 讼费用）。 是否会对上市公司损益产生负面影响：公司根据审慎性原则已在 2024 年审计报告中分别对本次诉讼事项涉及的相关资产计提专项减值准备。本次诉讼 事项预计对公司 2025 年度及期后利润不产生重大不利影响。 本次诉讼系依法维权行为，为维护公司的合法权益，公司将持续关注该事项 的进展，并将按照法律、法规的要求及时履行信息披露义务。敬请广大投资者注 意投资风险。 一、 本次诉讼起诉的基本情况 公司控股子公司广州瑞北就其与合创汽车的14个买卖 ...

一、 说明会类型 本次投资者说明会以网络互动形式召开，公司将针对 2024 年度及 2025 年第 一季度的经营成果及财务指标的具体情况与投资者进行互动交流和沟通，在信息 披露允许的范围内就投资者普遍关注的问题进行回答。 会议召开时间：2025 年 5 月 6 日(星期二)下午 15:00-17:00 会议召开方式：视频和线上文字互动 视频和线上文字互动平台：上海证券交易所上证路演中心 （http://roadshow.sseinfo.com/） 二、 说明会召开的时间、地点 证券代码：688090 证券简称：瑞松科技 公告编号：2025-011 广州瑞松智能科技股份有限公司 关于参加2024年度科创板机器人行业 集体业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： 投资者可于 2025 年 5 月 5 日(星期一)16:00 前通过邮件、电话等形式将需要 了解和关注的问题提前提供给公司。公司将在文字互动环节对投资者普遍关注的 问题进行回答。 广州瑞松智能科技股份有限公司（以下简称"公司" ...

Group 1 - China Aluminum reported a net profit of 12.4 billion yuan for 2024, an increase of 85.38% year-on-year, with a proposed cash dividend of 0.135 yuan per share [1] - Lihua Technology's net profit for 2024 decreased by 25.41% to 245 million yuan, with a proposed cash dividend of 0.7 yuan per 10 shares [1][2] - Zhongjing Food achieved a net profit of 175 million yuan in 2024, up 1.81% year-on-year, proposing a cash dividend of 8 yuan per 10 shares [3][4] - Sanwei Chemical's net profit fell by 6.92% to 263 million yuan, with a proposed cash dividend of 3 yuan per 10 shares [5] - Meino Biological's project for corn protein processing has received construction approval, with an investment of approximately 391 million yuan [6][7] Group 2 - Guangdian Electric's net profit surged by 411.28% to 74.73 million yuan, proposing a cash dividend of 0.7 yuan per 10 shares [13][14] - Xin'ao Co. reported a net profit of 4.493 billion yuan for 2024, down 36.64%, with a proposed cash dividend of 10.3 yuan per 10 shares [15] - Huaren Pharmaceutical's subsidiary received approval for a raw material drug, enhancing its product line [16] - Huanxin Technology received a project confirmation from BAIC Group for two display screen products, expected to enter mass supply [17] - Haitong Development plans to purchase four bulk carriers for a total of 59.25 million USD to expand its fleet [18] Group 3 - Guochuang High-tech won a bid for an asphalt procurement project worth 128 million yuan [22][23] - Huayi Pharmaceutical's subsidiary received overseas marketing approvals for several products [24] - Haisco's innovative drug HSK41959 has received clinical trial approval [25] - Hetai Machinery's subsidiary obtained a patent for a dust-proof chain technology [28] - Le Xin Medical's fetal heart rate monitor registration renewal application has been accepted [29] Group 4 - Feilong Co. became a designated supplier for an international client's electronic oil pump project, with expected sales of approximately 160 million yuan [29] - Yunnan Copper reported a net profit of 1.265 billion yuan for 2024, down 19.9%, with a proposed cash dividend of 2.4 yuan per 10 shares [42] - China Merchants Bank's net profit increased by 1.22% to 148.39 billion yuan, proposing a cash dividend of 20 yuan per 10 shares [43] - Shuanghui Development's net profit decreased by 1.26% to 4.989 billion yuan, with a proposed cash dividend of 7.5 yuan per 10 shares [44]

Group 1 - China Merchants Bank reported a net profit of 148.39 billion yuan for 2024, a year-on-year increase of 1.22%, with a proposed cash dividend of 2 yuan per share [1] - China Telecom announced a net profit of 33.01 billion yuan for 2024, reflecting an 8.4% year-on-year growth, with a proposed final dividend of 0.0927 yuan per share [2] - Double J Electric signed significant contracts worth 1.555 billion yuan, accounting for 44.35% of its audited revenue for 2023, which is expected to positively impact future performance [3] Group 2 - Yongding Co. clarified that it does not directly manufacture controllable nuclear fusion devices, and its related products will not significantly impact its financial performance [4] - Heng Rui Pharmaceutical entered a licensing agreement with Merck, potentially earning up to 1.77 billion USD in milestone payments [5] - Ruishun Technology plans to use 90 million yen (approximately 4.34 million yuan) of raised funds to acquire assets related to a high-precision parallel robot project from Panasonic [6] Group 3 - Dalian Heavy Industry expects a net profit of 160 million to 195 million yuan for Q1 2025, a year-on-year increase of 12.22% to 36.77%, driven by a projected revenue of around 3.5 billion yuan [9] - Rongsheng Development is planning to restructure its debts by consolidating assets and enhancing its operational capabilities [10] - Yunnan Copper's net profit for 2024 is projected to decline by 19.9%, with a proposed cash dividend of 2.4 yuan per share [11] Group 4 - Lianrui New Materials reported a net profit of 251 million yuan for 2024, a year-on-year increase of 44.47%, with a proposed stock dividend of 3 shares for every 10 shares held [11] - Yuan Zu Co. announced a net profit of 249 million yuan for 2024, a decrease of 9.98%, with a proposed cash dividend of 10 yuan per 10 shares [12] - Double Happiness Development reported a net profit of 4.989 billion yuan for 2024, a decrease of 1.26%, with a proposed cash dividend of 7.5 yuan per 10 shares [13] Group 5 - Morning Light Co. reported a net profit of 1.396 billion yuan for 2024, a decrease of 8.58%, with a proposed cash dividend of 10 yuan per 10 shares [14] - Ningbo Ocean's net profit for 2024 was 550 million yuan, reflecting a year-on-year growth of 9.86% [15] - Xinyue Kanglv reported a net profit of approximately 86.3 million yuan for 2024, a decrease of 42.2% [16] Group 6 - Zhongjian Technology expects a net profit of 100 million to 114 million yuan for Q1 2025, a year-on-year increase of 68.79% to 92.42% [17] - Kuaiyi Elevator reported a net profit of 132 million yuan for 2024, a decrease of 8.46%, with a proposed cash dividend of 3.6 yuan per 10 shares [18] - Rongsheng Environmental Protection reported a net profit of 286 million yuan for 2024, an increase of 5.79%, with a proposed cash dividend of 5 yuan per 10 shares [19] Group 7 - Minfeng Special Paper reported a net profit of 72 million yuan for 2024, an increase of 54.09%, with a proposed cash dividend of 0.17 yuan per 10 shares [20] - Huaiqi Environmental Protection announced that major shareholders plan to reduce their holdings by up to 1% [21] - Guoli Co. plans to repurchase shares worth 30 million to 50 million yuan [22]

瑞松科技: 广发证券股份有限公司关于广州瑞松智 能科技股份有限公司使用超募资金购买资产的核查 意见 广发证券股份有限公司 关于广州瑞松智能科技股份有限公司 使用超募资金购买资产的核查意见 广发证券股份有限公司（以下简称"广发证券"或"保荐机构"）作为广州瑞 松智能科技股份有限公司（以下简称"瑞松科技"或"公司"）首次公开发行股票 并在科创板上市及进行持续督导的保荐机构，根据《上市公司监管指引第 2 号 ——上市公司募集资金管理和使用的监管要求》《上海证券交易所科创板股票 上市规则》《上海证券交易所科创板上市公司自律监管指引第 1 号——规范运 作》等有关法律法规和规范性文件的要求，对公司本次使用超募资金购买资产 的事项进行了审慎核查，具体核查情况如下： 一、募集资金基本情况 经中国证券监督管理委员会《关于同意广州瑞松智能科技股份有限公司首次 公开发行股票注册的批复》（证监许可202052 号）核准，公司首次向社会公开 发行人民币普通股股票 16,840,147 股。公司由主承销商广发证券股份有限公司采 用向战略投资者定向配售、网下向符合条件的网下投资者询价配售和网上向持有 上海市场非限售 A 股股份和非限售存 ...

| 承诺投资项目 | 募集资金承诺 投资总额 | 调整后投资总额 | 累计投入金额 | 实施状态 | | --- | --- | --- | --- | --- | | 工业机器人及智能 装备生产基地项目 | 14,033.91 | 10,430.15 | 10,430.15 | 已结项 | | 研发中心建设项目 | 13,469.71 | 13,469.71 | 8,163.37 | 实施中 | | 偿还银行借款项目 | 6,000.00 | 6,000.00 | 6,020.04 | 已结项 | | 补充流动资金项目 | 4,000.00 | 4,000.00 | 4,021.67 | 已结项 | | 节余资金永久补充 流动资金 | - | 3,603.76 | 4,067.79 | 已补流 | | 超额募集资金项目 | - | 3,083.80 | 925.00 | 剩余 2158.80 万元 | | 合计 | 37,503.62 | 40,587.42 | 33,628.02 | - | 单位：万元 广发证券股份有限公司 关于广州瑞松智能科技股份有限公司 使用超募资金购买资产的核查意见 广发证券股份有 ...

证券代码：688090 证券简称：瑞松科技 公告编号：2025-009 广州瑞松智能科技股份有限公司 关于5%以上股东权益变动的提示性公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 本次权益变动为广州瑞松智能科技股份有限公司（以下简称"公司"或 "上市公司"或"瑞松科技"）持股 5%以上股东赵伟先生（以下简称"信息披露 义务人"）履行此前披露的减持股份计划所致，不触及要约收购。 本次权益变动后，赵伟先生持有公司的股份数量由 4,715,242 股变动至 4,709,642 股，占公司总股本的比例由 5.0059%减少至 4.9999%。 本次权益变动不会使公司控股股东、实际控制人发生变化，不会对公司 治理结构及未来持续经营产生重大影响。 公司于 2025 年 3 月 17 日收到股东赵伟先生出具的《简式权益变动报告书》， 现将其相关权益变动情况公告如下： 一、 本次权益变动基本情况 （一）信息披露义务人的基本情况 | 姓名 | 赵伟 | | --- | --- | | 性别 | 男 | | 国籍 | ...

简式权益变动报告书 上市公司名称：广州瑞松智能科技股份有限公司 广州瑞松智能科技股份有限公司 股票上市地点：上海证券交易所 信息披露义务人：赵伟 住所：福建省厦门市思明区**** 通讯地址：福建省厦门市湖里区**** 权益变动性质：集中竞价，股份减少 签署日期：2025年3月17日 股票简称：瑞松科技 股票代码：688090 信息披露义务人声明 一、本报告书系信息披露义务人依据《中华人民共和国证券法》《上市公司 收购管理办法》《公开发行证券的公司信息披露内容与格式准则第 15 号-权益变 动报告书》及相关法律、法规和规范性文件编写。 二、信息披露义务人签署本报告书已获得必要的授权和批准，其履行亦不违 反信息披露义务人章程或内部规则中的任何条款，或与之相冲突。 三、依据《中华人民共和国证券法》《上市公司收购管理办法》及《公开发 行证券的公司信息披露内容与格式准则第 15 号—权益变动报告书》的规定，本 报告书已全面披露信息披露义务人在广州瑞松智能科技股份有限公司中拥有权 益的股份变动情况。 2 | | 信息披露义务人声明 2 | | --- | --- | | 第一节 | 释义 4 | | 第二节 | 信息披露 ...

证券代码：688090 证券简称：瑞松科技 公告编号：2025-008 广州瑞松智能科技股份有限公司 关于子公司涉及诉讼事项的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示: 案件所处的诉讼阶段：收到二审判决书，终审判决为生效判决。 上市公司所处的当事人地位：广州瑞松智能科技股份有限公司（以下简 称"公司"）控股子公司广州瑞松北斗汽车装备有限公司（以下简称"广州瑞北"） 为本案一审原告、被上诉人。 涉案金额：起诉四被告姚振华、深圳市宝能投资集团有限公司（（以下 简称"宝能投资"）、观致汽车有限公司（以下简称"观致汽车"）、观致汽车 有限公司西安分公司（以下简称"观致西安"）连带支付人民币 3,714 万元；追 加起诉被告观致汽车有限公司、观致汽车有限公司西安分公司支付人民币 1,294 万元（以上金额未含逾期付款利息、诉讼费用）。 子公司广州瑞北因与因与姚振华、宝能投资、观致汽车、观致西安的保证合 同纠纷，向深圳市罗湖区人民法院起诉四名被告连带支付人民币 3,714 万元；追 1 加起诉被告观致汽车 ...

Financial Performance - Total revenue for 2024 was RMB 88,678.23 million, a decrease of 12.69% compared to the previous year[3] - Net profit attributable to shareholders was RMB 1,144.30 million, down 76.76% year-on-year[3] - The net profit excluding non-recurring gains and losses was RMB 226.73 million, a decline of 85.09% compared to the previous year[3] - Basic earnings per share decreased to RMB 0.12, down 77.36% from RMB 0.53 in the previous year[3] Assets and Equity - Total assets at the end of the reporting period were RMB 159,801.05 million, a decrease of 5.43% from the beginning of the period[5] - Shareholders' equity attributable to the parent company was RMB 89,938.62 million, a slight decrease of 0.22%[5] Strategic Focus - The company focused on "robotics + artificial intelligence" strategy, investing in R&D for new technologies[5] Capital Changes - The increase in share capital by 39.84% was due to the capitalization of capital reserves during the reporting period[6] Operational Challenges - The company faced challenges from reduced order volumes and delayed project acceptance, impacting revenue[5] Financial Data Disclaimer - The company issued a risk warning regarding the preliminary nature of the financial data, which has not been audited[7]